




Searching News Database: Teva Pharmaceuticals
HSMN NewsFeed - 30 Aug 2023
Alkermes Announces Settlement With Teva Related to VIVITROL(R) Patent Litigation
Alkermes Announces Settlement With Teva Related to VIVITROL(R) Patent Litigation
HSMN NewsFeed - 21 Nov 2019
STI Pharma Appoints Frank Mullery as President and Chief Commercial Officer
STI Pharma Appoints Frank Mullery as President and Chief Commercial Officer
HSMN NewsFeed - 1 Jun 2018
Fortuna Fix Announces Appointment of Madhavan Balachandran to Board of Directors
Fortuna Fix Announces Appointment of Madhavan Balachandran to Board of Directors
HSMN NewsFeed - 20 Apr 2018
Lannett Names Maureen Cavanaugh Senior Vice President And Chief Commercial Operations Officer
Lannett Names Maureen Cavanaugh Senior Vice President And Chief Commercial Operations Officer
HSMN NewsFeed - 2 Nov 2017
BrainStorm Strengthens Executive Team: Appoints Eyal Rubin as Chief Financial Officer
BrainStorm Strengthens Executive Team: Appoints Eyal Rubin as Chief Financial Officer
HSMN NewsFeed - 13 Sep 2017
Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer
Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer
HSMN NewsFeed - 19 Jul 2017
AcelRx Pharmaceuticals Appoints Raffi Asadorian as Chief Financial Officer
AcelRx Pharmaceuticals Appoints Raffi Asadorian as Chief Financial Officer
HSMN NewsFeed - 3 Aug 2016
Allergan Announces Sale of Anda Distribution Business to Teva Pharmaceutical
Allergan Announces Sale of Anda Distribution Business to Teva Pharmaceutical
HSMN NewsFeed - 19 May 2016
BioLight Expands Its Product Portfolio With Eye Drops for Dry Eye Syndrome
BioLight Expands Its Product Portfolio With Eye Drops for Dry Eye Syndrome
HSMN NewsFeed - 3 May 2016
Patara Pharma Appoints Biotechnology Industry Leader John Schmid to Board of Directors
Patara Pharma Appoints Biotechnology Industry Leader John Schmid to Board of Directors
HSMN NewsFeed - 2 May 2016
Endo Announces U.S. District Court Ruling Upholding OPANA(R) ER Intellectual Property
Endo Announces U.S. District Court Ruling Upholding OPANA(R) ER Intellectual Property
HSMN NewsFeed - 24 Feb 2016
Alexza Pharmaceuticals Reacquires U.S. Commercial Rights for ADASUVE(R) (loxapine) inhalation powder
Alexza Pharmaceuticals Reacquires U.S. Commercial Rights for ADASUVE(R) (loxapine) inhalation powder
HSMN NewsFeed - 27 Apr 2015
Synta Announces Chen Schor Named President, Chief Executive Officer and Director
Synta Announces Chen Schor Named President, Chief Executive Officer and Director
HSMN NewsFeed - 21 May 2014
Provectus Biopharmaceuticals Inc. Appoints Jacob M. Plotsker to Strategic Advisory Board
Provectus Biopharmaceuticals Inc. Appoints Jacob M. Plotsker to Strategic Advisory Board
HSMN NewsFeed - 9 Jan 2014
Sorrento Therapeutics Welcomes William S. Marth as Chairman of the Board of Directors
Sorrento Therapeutics Welcomes William S. Marth as Chairman of the Board of Directors
HSMN NewsFeed - 28 Jan 2013
BrainStorm Cell Therapeutics Appoints Alon Natanson as Chief Executive Officer
BrainStorm Cell Therapeutics Appoints Alon Natanson as Chief Executive Officer
HSMN NewsFeed - 28 Jan 2013
Genzyme’s LEMTRADA(TM) (alemtuzumab) Application for MS Accepted for Review by the FDA
Genzyme’s LEMTRADA(TM) (alemtuzumab) Application for MS Accepted for Review by the FDA
HSMN NewsFeed - 26 Oct 2012
Teva Receives Approval For SYNRIBO(TM) (Omacetaxine Mepesuccinate) for Injection
Teva Receives Approval For SYNRIBO(TM) (Omacetaxine Mepesuccinate) for Injection
HSMN NewsFeed - 4 Oct 2012
BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Merger Agreement
BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Merger Agreement
HSMN NewsFeed - 14 Sep 2012
Impax Laboratories Announces Settlement of Litigation Relating to CONCERTA(R)
Impax Laboratories Announces Settlement of Litigation Relating to CONCERTA(R)
HSMN NewsFeed - 17 Jan 2012
Aerocrine appoints pulmonologist Paul Dorinsky, M.D., as medical director, North America
Aerocrine appoints pulmonologist Paul Dorinsky, M.D., as medical director, North America
HSMN NewsFeed - 5 Dec 2011
INSYS Therapeutics Announces Addition of VP of Marketing to Commercial Team
INSYS Therapeutics Announces Addition of VP of Marketing to Commercial Team
HSMN NewsFeed - 3 Oct 2011
The Medicines Company Settles Angiomax(R) (Bivalirudin) Patent Litigations With Teva
The Medicines Company Settles Angiomax(R) (Bivalirudin) Patent Litigations With Teva
HSMN NewsFeed - 22 Sep 2011
Eleven Biotherapeutics Appoints Abbie Celniker, Ph.D., Chief Executive Officer
Eleven Biotherapeutics Appoints Abbie Celniker, Ph.D., Chief Executive Officer
HSMN NewsFeed - 6 Sep 2011
Impax Laboratories Appoints Carole Ben-Maimon, M.D. President of Global Pharmaceuticals
Impax Laboratories Appoints Carole Ben-Maimon, M.D. President of Global Pharmaceuticals
HSMN NewsFeed - 14 Feb 2011
BioSante Pharmaceuticals Reports Positive LibiGel(R) Safety Data in Phase III Program
BioSante Pharmaceuticals Reports Positive LibiGel(R) Safety Data in Phase III Program
HSMN NewsFeed - 29 Sep 2010
Mersana Therapeutics Appoints Nicholas Bacopoulos President and Chief Executive Officer
Mersana Therapeutics Appoints Nicholas Bacopoulos President and Chief Executive Officer
HSMN NewsFeed - 14 Apr 2010
POZEN Enters into Settlement Agreement With Teva Regarding Paragraph IV Patent Litigation
POZEN Enters into Settlement Agreement With Teva Regarding Paragraph IV Patent Litigation
HSMN NewsFeed - 16 Feb 2010
Aton Pharma Appoints Dr. Wayne Mulcahy to Vice President, Clinical Operations
Aton Pharma Appoints Dr. Wayne Mulcahy to Vice President, Clinical Operations
HSMN NewsFeed - 9 Feb 2010
BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs
BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs
HSMN NewsFeed - 22 Apr 2009
Lilly Granted Preliminary Injunction to Prevent Launch of Generic Raloxifene
Lilly Granted Preliminary Injunction to Prevent Launch of Generic Raloxifene
HSMN NewsFeed - 9 Mar 2009
Lilly Granted Temporary Restraining Order to Halt Launch of Generic Raloxifene
Lilly Granted Temporary Restraining Order to Halt Launch of Generic Raloxifene
HSMN NewsFeed - 4 Feb 2009
Neurobiological Technologies Announces Appointment of William A. Fletcher as Acting CEO
Neurobiological Technologies Announces Appointment of William A. Fletcher as Acting CEO
HSMN NewsFeed - 7 Mar 2008
Pfizer Wins Challenge to Two Main U.S. Patents for Celebrex by Generic Manufacturer Teva
Pfizer Wins Challenge to Two Main U.S. Patents for Celebrex by Generic Manufacturer Teva
HSMN NewsFeed - 28 Feb 2008
Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel
Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel
HSMN NewsFeed - 7 Jan 2008
Antares Pharma Develops Novel Pen Injector under New Agreement with Teva Pharmaceuticals
Antares Pharma Develops Novel Pen Injector under New Agreement with Teva Pharmaceuticals
HSMN NewsFeed - 27 Dec 2007
U.S. District Court Decision About Eisai's Legal Action Over Aricept ODT(R) ANDA Filing
U.S. District Court Decision About Eisai's Legal Action Over Aricept ODT(R) ANDA Filing
HSMN NewsFeed - 27 Aug 2007
BioLineRx In-Licenses Novel Drug for the Treatment of Acute Kidney Injury
BioLineRx In-Licenses Novel Drug for the Treatment of Acute Kidney Injury
HSMN NewsFeed - 22 Aug 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
HSMN NewsFeed - 6 Feb 2007
Barr's Subsidiary PLIVA Receives Final Approval for Generic ZOLOFT(R) Tablets, 25 mg, 50 mg and 100 mg
Barr's Subsidiary PLIVA Receives Final Approval for Generic ZOLOFT(R) Tablets, 25 mg, 50 mg and 100 mg
HSMN NewsFeed - 19 Jan 2007
Barr Launches Generic METAGLIP(TM) Tablets, 2.5/250 mg, 2.5/500 mg and 5/500 mg
Barr Launches Generic METAGLIP(TM) Tablets, 2.5/250 mg, 2.5/500 mg and 5/500 mg
HSMN NewsFeed - 29 Aug 2006
Purdue Pharma L.P. Announces Agreement to End OxyContin(R) Patent Lawsuit with Teva Pharmaceuticals
Purdue Pharma L.P. Announces Agreement to End OxyContin(R) Patent Lawsuit with Teva Pharmaceuticals
HSMN NewsFeed - 5 Apr 2006
Teva Announces That Higher Dose of Copaxone(R) Showed Increased Efficacy in Multiple Sclerosis (MS)
Teva Announces That Higher Dose of Copaxone(R) Showed Increased Efficacy in Multiple Sclerosis (MS)
HSMN NewsFeed - 3 Mar 2006
Shire Sues Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc.
Shire Sues Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc.
HSMN NewsFeed - 8 Feb 2006
Pfizer Petitions FDA to Recall Teva and Sandoz Generic Azithromycin Products to Correct Misbranding
Pfizer Petitions FDA to Recall Teva and Sandoz Generic Azithromycin Products to Correct Misbranding
HSMN NewsFeed - 18 Jan 2006
ADDERALL XR(R) - Paragraph IV Notice Update - Third Notice Letter From Teva Pharmaceuticals USA, Inc.
ADDERALL XR(R) - Paragraph IV Notice Update - Third Notice Letter From Teva Pharmaceuticals USA, Inc.
Additional items found! 46

Members Archive contains
46 additional stories matching:
Teva Pharmaceuticals
(Password required)
Teva Pharmaceuticals
(Password required)